Hous­ton's Avance Bio­sciences an­nounces an­oth­er ex­pan­sion, this time fo­cused on cell-based as­says

With its foot in the door of biotech’s bur­geon­ing cell and gene ther­a­py in­dus­try, Hous­ton’s Avance Bio­sciences is tak­ing ad­van­tage of what it says is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.